Catharina Eriksson

Kontakt

catharina.eriksson@umu.se

090-785 12 54

Verksam vid

Anknuten som forskare till Institutionen för klinisk vetenskap Enhet: Pediatrik

Umeå universitet, Klinisk vetenskap, 901 85 Umeå

Anknuten som läkare till Institutionen för klinisk mikrobiologi Enhet: Klinisk immunologi

6B, Universitetssjukhuset, Klinisk immunologi Umeå universitet, 901 85 Umeå

Publikationer Publikationer

How children and adolescents with juvenile idiopathic arthritis participate in their healthcare: health professionals' views

Disability and Rehabilitation

Lundberg, Veronica; Sandlund, Marlene; Eriksson, Catharina; et al.

Quality and best practice in medical laboratories: specific requests for autoimmunity testing

Autoimmun Highlights, Springer 2020, Vol. 11, (1)

Sack, Ulrich; Bossuyt, Xavier; Andreeva, Hristina; et al.

Current laboratory and clinical practices in reporting and interpreting anti-nuclear antibody indirect immunofluorescence (ANA IIF) patterns: results of an international survey

AUTOIMMUNITY HIGHLIGHTS, Springer 2020, Vol. 11, (1)

Van Hoovels, Lieve; Broeders, Sylvia; Chan, Edward K. L.; et al.

An international survey on anti-neutrophil cytoplasmic antibodies (ANCA) testing in daily clinical practice

Clinical Chemistry and Laboratory Medicine, Walter de Gruyter 2018, Vol. 56, (10) : 1759-1770

Damoiseaux, Jan; Heijnen, Ingmar; Van Campenhout, Christel; et al.

Survivin improves the early recognition of rheumatoid arthritis among patients with arthralgia: A population-based study within two university cities of Sweden

Seminars in Arthritis & Rheumatism, Saunders Elsevier 2018, Vol. 47, (6) : 778-785

Erlandsson, Malin C.; Turkkila, Minna; Siljehult, Filip; et al.

Concentrations of infliximab and anti-drug antibodies in relation to clinical response in patients with rheumatoid arthritis

Scandinavian Journal of Rheumatology, Taylor & Francis Group 2018, Vol. 47, (5) : 345-350

Siljehult, Filip; Ärlestig, Lisbeth; Eriksson, Catharina; et al.

International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies

Annals of the Rheumatic Diseases, BMJ Publishing Group 2014, Vol. 73, (1) : 17-23

Agmon-Levin, Nancy; Damoiseaux, Jan; Kallenberg, Cees; et al.

From ANA-screening to antigen-specificity: an EASI-survey on the daily practice in European countries

Clinical and Experimental Rheumatology, Vol. 32, (4) : 539-546

Damoiseaux, J.; Agmon-Levin, N.; Van Blerk, M.; et al.

Cytokines in relation to autoantibodies before onset of symptoms for systemic lupus erythematosus

Lupus, Sage Publications 2014, Vol. 23, (7) : 691-696

Eriksson, Catharina; Rantapää Dahlqvist, Solbritt

S-Calprotectin (S100A8/S100A9): A Potential Marker of Inflammation in Patients with Psoriatic Arthritis

Clinical & Developmental Immunology : 696415-

Hansson, Claes; Eriksson, Catharina; Alenius, Gerd-Marie

Changes in chemokines and their receptors in blood during treatment with the TNF inhibitor infliximab in patients with rheumatoid arthritis

Scandinavian Journal of Rheumatology, Vol. 42, (4) : 260-265

Eriksson, Catharina; Rantapää-Dahlqvist, Solbritt; Sundqvist, KG

Genes identified in Asian SLE GWASs are also associated with SLE in Caucasian populations

European Journal of Human Genetics, Vol. 21, (9) : 994-999

Wang, Chuan; Ahlford, Annika; Järvinen, Tiina M; et al.

Cytokines and Their Relation to Autoantibodies Before Disease Onset in Systemic Lupus Erythematosus

Arthritis and Rheumatism, Vol. 64, (10) : S286-S287

Eriksson, Catharina; Dahlqvist, Solbritt Rantapää

Pediatric Rheumatology, Vol. 10

Lundberg, Veronica; Lindh, Viveca; Eriksson, Catharina; et al.

Immunological mechanisms in systemic autoimmunity: autoantibodies and chemokines in systemic lupus erythematosus and during treatment with TNF inhibitors in rheumatoid arthritis

Umeå University medical dissertations, 1401

Eriksson, Catharina

Autoantibodies predate the onset of Systemic Lupus Erythematosus in northern Sweden

Arthritis Research & Therapy, Vol. 13, (1) : R30-

Eriksson, Catharina; Kokkonen, Heidi; Johansson, Martin; et al.

A candidate gene study of the type I interferon pathway implicates IKBKE and IL8 as risk loci for SLE

European Journal of Human Genetics, Vol. 19, (4) : 479-484

Sandling, Johanna K; Garnier, Sophie; Sigurdsson, Snaevar; et al.

T-cell expression of CD91: a marker of unresponsiveness to anti-TNF therapy in rheumatoid arthritis

Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS), Vol. 118, (11) : 837-845

Eriksson, Catharina; Rantapää-Dahlqvist, Solbritt; Sundqvist, Karl-Gösta

Atherosclerosis in early rheumatoid arthritis: very early endothelial activation and rapid progression of intima media thickness

Arthritis Research & Therapy, Vol. 12, (4) : R158-

Södergren, Anna; Karp, Kjell; Boman, Kurt; et al.

Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides

Journal of Rheumatology, Vol. 35, (6) : 1002-1008

Innala, Lena; Kokkonen, Heidi; Eriksson, Catharina; et al.

Autoantibody formation in patients with rheumatoid arthritis treated with anti-TNF alpha

Annals of the Rheumatic Diseases, Vol. 64, (3) : 403-407

Eriksson, Catharina; Engstrand, S; Sundqvist, K-G; et al.

Abnormal expression of chemokine receptors on T-cells from patients with systemic lupus erythematosus

Lupus, Vol. 12, (10) : 766-774

Eriksson, Catharina; Eneslätt, Kjell; Ivanoff, J; et al.

How children with juvenile idiopathic arthritis experience participation and communication in healthcare encounters: Children’s, young adults’ and parents’ views

Lundberg, Veronica; Eriksson, Catharina; Lind, Torbjörn; et al.

How children with juvenile idiopathic arthritis participate in their healthcare: Health professionals' views

Lundberg, Veronica; Sandlund, Marlene; Eriksson, Catharina; et al.

Visa publikationer i DiVA